Joshua Yang

The 21 Fund is group supporting the next generation of Stanford Graduate School of Business (GSB) startups. "The Fund" offers ongoing support to our entrepreneurs and fosters lifelong relationships within the class of 2021. Our mission is to be the most hands-on and value-add partner to every GSB ‘21 founder. We leverage the strength and breadth of experience of our class through a network of 230+ individuals from the class of 2021 and a dedicated Platform Team for portfolio support. Follow us on Twitter at @21_fund.

Founded in 1984, Bain Capital is one of the world’s leading private investment firms. We are committed to creating lasting impact for our investors, teams, businesses, and the communities in which we live. As a private partnership, we lead with conviction and a culture of collaboration, advantages that enable us to innovate investment approaches, unlock opportunities, and create exceptional outcomes. Our global platform invests across five focus areas: Private Equity, Growth & Venture, Capital Solutions, Credit & Capital Markets, and Real Assets. In these focus areas, we bring deep sector expertise and wide-ranging capabilities. We have 24 offices on four continents, more than 1,850 employees, and approximately $185 billion in assets under management. To learn more, visit www.baincapital.com. Follow @BainCapital on LinkedIn and X (Twitter).

The 21 Fund is group supporting the next generation of Stanford Graduate School of Business (GSB) startups. "The Fund" offers ongoing support to our entrepreneurs and fosters lifelong relationships within the class of 2021. Our mission is to be the most hands-on and value-add partner to every GSB ‘21 founder. We leverage the strength and breadth of experience of our class through a network of 230+ individuals from the class of 2021 and a dedicated Platform Team for portfolio support. Follow us on Twitter at @21_fund.

We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.

Southeast Asia Exponential Ventures (SeaX) is a VC fund investing globally in early-stage companies with game-changing “exponential” technologies. Our focus areas are Foodtech, Biotech & Life Science, AI, Robotics, Blockchain, Quantum Computing, and Sustainability Tech. We leverage RISEs relationship with over 400+ listed companies, MNCs, and huge family businesses in Southeast Asia to explore business opportunities together with our portfolio companies.

The InSITE Fellowship is a highly competitive leadership development program comprised of exceptional graduate students at top universities, including Columbia, NYU, Harvard, MIT, Stanford, Georgetown, and several medical research institutions. InSITE Fellows and alumni make up a global network of entrepreneurs and leaders in technology and venture capital. InSITE was founded in 1999 with a mission to create a community of passionate leaders who share common values and have the desire, ability, and network to support innovative companies and projects around the nation. We identify talented students from a diverse range of backgrounds and connect them with hand-picked, high-potential emerging companies in a variety of industries. Students meet with founders and company leaders, identify key challenges and opportunities, set deliverables, and complete semester-long projects that contribute to real growth. Each semester, the New York chapter of InSITE receives over 150 applications for eight projects. After careful due diligence, the InSITE community selects those projects it sees as most promising and most viable. Projects vary, depending on the individual company’s most pressing need. In the past, fellows have worked on projects centered around the formation of pitch materials, marketing and brand development, product development, consumer research, and pricing strategy, among others. To date, InSITE companies have raised more than $300 million of disclosed funding and have enjoyed many successful exits.